News

A subsidiary of Glenmark Pharmaceuticals Limited India (GPL), GPSA’s GRC 15300 is an inhibitor of the TRPV3 and has demonstrated significant pharmacokinetic profile in the trial. The results

Dutasteride and tamsulosin hydrochloride capsules of Watson Pharma are the generic version of GSK‘s JALYN, which is used to treat symptomatic benign prostatic hyperplasia (BPH) in men suffering

The company plans to call for an end-of review meeting with the FDA to comprehend the details of the CRL and to discuss regarding further steps to be

The investment allows HBYS commercial team to also sell third party products in all provinces in China. HBYS will invest $3.2m for a 60% equity interest in NBHG

The lymph nodes are located using a radioactive signal with a hand-held radioactive tracer and are surgically removed and analyzed to determine if tumor cells are present. Clinical

Further, A*Star has chosen Agilent to offer automation technologies to biomedical researchers, enabling efficient drug screening in one location. A*STAR has now deployed Agilent’s dual BioCel 1200 integrated

The MAA submission was based on the RHODOS study results which was, a placebo-controlled, randomized trial and has demonstrated efficacy of idebenone in LHON. The MAA also includes

APC-100 is an orally available anti-androgenic/anti-inflammatory, signal transduction inhibitor drug. The recently issued patent strengthens company’s patent portfolio for the use of APC-100 in the treatment of early

Revolade, an oral platelet generator is used to treat thrombocytopenia (reduced platelet count) in adults with the blood disorder chronic immune (idiopathic) thrombocytopenic purpura (ITP) who have had